LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
35.50
+1.18 (3.44%)
Nov 22, 2024, 4:00 PM EST - Market closed
LENZ Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -60.81 | -69.97 | -10.81 | -7.56 |
| Depreciation & Amortization | 0.04 | 0.02 | 0.01 | 0 |
| Loss (Gain) From Sale of Investments | -3.1 | -1.06 | - | - |
| Stock-Based Compensation | 5.25 | 1.34 | 0.72 | 0.2 |
| Other Operating Activities | 0.78 | -0.12 | -0.02 | 0.82 |
| Change in Accounts Payable | -4.51 | 0.86 | 4.3 | 0.38 |
| Change in Other Net Operating Assets | -8.93 | 8.55 | 1.72 | 0.77 |
| Operating Cash Flow | -71.28 | -60.38 | -4.09 | -5.39 |
| Capital Expenditures | -0.32 | -0.03 | -0.04 | -0.01 |
| Investment in Securities | -127.12 | -29.59 | - | - |
| Investing Cash Flow | -127.44 | -29.62 | -0.04 | -0.01 |
| Issuance of Common Stock | 83.5 | 0.2 | 0.13 | - |
| Other Financing Activities | 113.54 | -2.48 | - | - |
| Financing Cash Flow | 197.04 | 80.7 | 30.26 | 22.77 |
| Net Cash Flow | -1.69 | -9.3 | 26.13 | 17.36 |
| Free Cash Flow | -71.6 | -60.41 | -4.13 | -5.4 |
| Free Cash Flow Margin | - | - | -27.52% | - |
| Free Cash Flow Per Share | -3.17 | -6.23 | -0.44 | -0.58 |
| Levered Free Cash Flow | -49.26 | -34.21 | 0.1 | - |
| Unlevered Free Cash Flow | -49.26 | -34.21 | 0.1 | - |
| Change in Net Working Capital | 11.5 | -9.73 | -5.96 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.